Elanco Animal Healthの空売り状況は、投資家がElanco Animal Healthの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Elanco Animal Health (NYSE:ELAN) 株価情報, 空売り情報

Elanco Animal Health

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health Inc

ELANIX BIOTECHNOLOGIES AG by ELANIX BIOTECHNOLOGIES AG

Earnings

Earnings Beats

Earnings Misses

News

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

Maxeon Solar Technologies Q4 EPS $(6.60), Sales $48.81M

<h3>Gainers</h3>
<ul>
<li>Yunhong Green CTI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YHGJ#NASDAQ">YHGJ</a>) shares increased by 16.6% to $0.98 during Wednesday's after-market session. The market value of their outstanding shares is at $25.3 million. </li>
<li>Camping World Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWH#NYSE">CWH</a>) stock moved upwards by 11.63% to $13.46. The company's market cap stands at $809.5 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Haverty Furniture Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HVT#NYSE">HVT</a>) stock rose 10.13% to $20.0. The company's market cap stands at $324.9 million. As per the press release, Q1 earnings came out today. </li>
<li>Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) shares moved upwards by 7.52% to $0.47. The company's market cap stands at $20.1 million. </li>
<li>Hall Of Fame Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFV#NASDAQ">HOFV</a>) shares increased by 5.0% to $0.73. The company's market cap stands at $4.8 million. </li>
<li>First Watch Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) shares moved upwards by 4.98% to $18.54. The company's market cap stands at $1.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>INNEOVA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INEO#NASDAQ">INEO</a>) shares declined by 8.3% to $1.31 during Wednesday's after-market session. The market value of their outstanding shares is at $12.9 million. </li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) stock declined by 8.26% to $0.39. The company's market cap stands at $3.3 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares declined by 7.86% to $0.25. The market value of their outstanding shares is at $1.7 million. </li>
<li>Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) stock declined by 7.12% to $2.21. The market value of their outstanding shares is at $5.2 million. </li>
<li>Linkage Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCB#NASDAQ">LGCB</a>) stock fell 5.73% to $1.81. The market value of their outstanding shares is at $5.5 million. </li>
<li>Mixed Martial Arts Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) shares declined by 5.59% to $0.81. The company's market cap stands at $8.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

FWRG

HOFV

INEO

LGCB

LVLU

SBET

XELB

YHGJ

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

Rayonier (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYN#NYSE">RYN</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.06 by 133.33 percent. This is a 300 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $82.90 million which missed the analyst consensus estimate of $153.12 million by 45.86 percent. This is a 27.09 percent decrease over sales of $113.70 million the same period last year.

Rayonier Q1 Adj. EPS $(0.02) Misses $0.06 Estimate, Sales $82.90M Miss $153.12M Estimate

<h3>Gainers</h3>
<ul>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) shares increased by 45.1% to $4.15 during Wednesday's after-market session. The company's market cap stands at $3.4 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares increased by 15.64% to $0.2. The company's market cap stands at $5.1 million. </li>
<li>Ainos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMD#NASDAQ">AIMD</a>) stock rose 13.18% to $0.6. The market value of their outstanding shares is at $9.2 million. </li>
<li>Processa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) stock increased by 13.16% to $0.28. The company's market cap stands at $1.4 million. </li>
<li>Auna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUNA#NYSE">AUNA</a>) shares rose 11.43% to $7.7. The market value of their outstanding shares is at $569.8 million. </li>
<li>Iridex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRIX#NASDAQ">IRIX</a>) shares rose 10.08% to $1.31. The market value of their outstanding shares is at $21.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>INVO Fertility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVF#NASDAQ">IVF</a>) shares declined by 7.5% to $2.21 during Wednesday's after-market session. The company's market cap stands at $10.9 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Palatin Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PTN#AMEX">PTN</a>) shares fell 7.31% to $0.19. The market value of their outstanding shares is at $4.8 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) stock declined by 6.95% to $11.39. The market value of their outstanding shares is at $7.6 million. </li>
<li>Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) shares declined by 6.94% to $0.31. The market value of their outstanding shares is at $19.2 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares fell 6.46% to $0.29. The company's market cap stands at $11.5 million. </li>
<li>Baird Medical Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) stock fell 6.26% to $5.55. The market value of their outstanding shares is at $201.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIMD

AUNA

BDMD

GCTK

IRIX

JAGX

NAOV

PASG

PCSA

PLRZ

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock moved upwards by 8.8% to $0.35 during Wednesday's after-market session. The market value of their outstanding shares is at $49.3 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) shares rose 8.58% to $3.63. The market value of their outstanding shares is at $121.2 million. </li>
<li>Skycorp Solar Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PN#NASDAQ">PN</a>) stock increased by 7.4% to $2.61. The company's market cap stands at $70.4 million. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) shares rose 7.02% to $0.44. The company's market cap stands at $34.9 million. </li>
<li>Sunrise New Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPOW#NASDAQ">EPOW</a>) shares increased by 6.06% to $1.05. The company's market cap stands at $27.4 million. </li>
<li>Baiya International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIYA#NASDAQ">BIYA</a>) stock moved upwards by 5.88% to $4.32. The company's market cap stands at $54.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) shares decreased by 6.7% to $2.66 during Wednesday's after-market session. The company's market cap stands at $4.7 million. </li>
<li>FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) shares declined by 6.61% to $100.03. The market value of their outstanding shares is at $10.2 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) shares decreased by 6.41% to $0.99. The company's market cap stands at $4.1 million. </li>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) shares declined by 5.95% to $4.12. The market value of their outstanding shares is at $11.5 million. </li>
<li>Simpple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) stock declined by 5.85% to $3.56. The company's market cap stands at $12.5 million. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) shares declined by 5.07% to $0.56. The company's market cap stands at $28.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BGLC

BIYA

CLIR

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

FTAI

LGCL

NEOV

SCWO

SGLY

SPPL

VCIG

12 Industrials Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>TTM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) shares increased by 19.3% to $23.89 during Wednesday's after-market session. The company's market cap stands at $2.4 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) shares moved upwards by 16.01% to $0.63. The market value of their outstanding shares is at $1.2 million. </li>
<li>Netgear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTGR#NASDAQ">NTGR</a>) stock moved upwards by 14.01% to $27.5. The company's market cap stands at $791.4 million. As per the press release, Q1 earnings came out today. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) shares increased by 13.54% to $1.09. The company's market cap stands at $4.2 million. </li>
<li>Tungray Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) shares moved upwards by 8.72% to $1.87. The market value of their outstanding shares is at $30.5 million. </li>
<li>Olo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLO#NYSE">OLO</a>) stock increased by 8.06% to $6.7. The company's market cap stands at $1.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) stock decreased by 11.8% to $21.01 during Wednesday's after-market session. The market value of their outstanding shares is at $7.1 billion. As per the press release, Q1 earnings came out today. </li>
<li>Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) shares fell 6.0% to $139.56. The market value of their outstanding shares is at $154.3 billion. As per the news, the Q2 earnings report came out today. </li>
<li>JFrog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) shares fell 5.22% to $32.01. The market value of their outstanding shares is at $3.6 billion. </li>
<li>Orangekloud Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) stock decreased by 5.18% to $0.52. The market value of their outstanding shares is at $12.0 million. </li>
<li>BIT Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) stock declined by 5.03% to $1.7. The company's market cap stands at $25.8 million. </li>
<li>Forward Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORD#NASDAQ">FORD</a>) shares decreased by 4.89% to $6.42. The market value of their outstanding shares is at $7.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BTCM

CFLT

FORD

FROG

NTGR

ORKT

PRSO

QCOM

TRSG

TTMI

12 Information Technology Stocks Moving In Wednesday's After-Market Session

Bogota Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSBK#NASDAQ">BSBK</a>) reported quarterly earnings of $0.06 per share. This is a 300 percent increase over losses of $(0.03) per share from the same period last year. The company reported $4.48 million in sales this quarter. This is a 51.95 percent increase over sales of $2.95 million the same period last year.

BSBK

Bogota Finl Q1 EPS $0.06 Up From $(0.03) YoY, Sales $4.48M Up From $2.95M YoY

Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network&#xAE; (NCCN) guidelines' 5% threshold to forgo sentinel lymph node biopsy (SLNB) surgery
FRIENDSWOOD, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>), a company improving health through innovative tests that guide patient care, today announced the publication of a new study in <a href="https://www.globenewswire.com/Tracker?data=BZ6ceShPMCBqcPuHfCc9jfNh8yuizOG9su8ZO2Y4xOhIZkgB1xMpnQI-U-iEbeSIOGQzFwelVyLSWXuzqACmQZY28M-Bu0GoSRw1yFzczQcxBBt9vhZTppnR0q1k9MyxHZJTXNAlAGNSg9HwCoGvxLQA6t4e3DZ26ORHx7jw8lPskys12_z7ITON9lzyQFybMXDR5utMiU6XgtFe_F6RbgvJ92CUaGvDZYIJSvvPGElZgmVfukpk7OwUXZZLHwuFa6xm3jFVNv9bX4lr5z8k4m6v9n5uzn3dpk0sjgeZbgy6lfaopK6nLZaS4XrEJQef8R3s3EI8Dv3j-eV_t5qI0SR1_huRLF1Fn_c11ncF5Tc=">Cancer Diagnosis &amp; Prognosis</a> demonstrating that DecisionDx-Melanoma outperforms both American Joint Committee on Cancer (AJCC) staging and the CP-GEP test (clinicopathological and gene expression profiling model) in identifying patients at low risk of SLN positivity who may consider forgoing SLNB surgery.

CSTL

Castle Biosciences' New Study In Cancer Diagnosis & Prognosis Demonstrates That DecisionDx-melanoma Outperforms Both AJCC Staging And CP-GEP Test

Alamos Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.23 by 39.13 percent. This is a 7.69 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $333.00 million which missed the analyst consensus estimate of $357.18 million by 6.77 percent. This is a 19.96 percent increase over sales of $277.60 million the same period last year.

Alamos Gold Q1 Adj. EPS $0.14 Misses $0.23 Estimate, Sales $333.00M Miss $357.18M Estimate

Alamos Gold (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AGI#TSX">AGI</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.19 by 26.32 percent. This is a 7.69 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $333.00 million which missed the analyst consensus estimate of $378.45 million by 12.01 percent. This is a 2.47 percent increase over sales of $324.98 million the same period last year.

TSX:AGI

Alamos Gold Q1 Adj. EPS $0.14 Misses $0.19 Estimate, Sales $333.00M Miss $378.45M Estimate

Smurfit Westrock plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>, LSE: SWR))) today announced it will permanently close its coated recycled board (CRB) mill in St. Paul, Minnesota, U.S. and will discontinue production at its containerboard mill in Forney, Texas, U.S. The specialty coating facility at Forney will not be impacted. As a result, the Company's containerboard and CRB capacity is expected to reduce by over 500,000 tons.
Smurfit Westrock has also initiated consultations with local works councils in Germany with a view to permanently closing two converting facilities there.
Approximately 650 employees in the U.S. and Germany will be impacted as a result of these closures. We recognize the impact this has on our employees and the communities involved. We will provide support to employees during this transition including career transition assistance and relocation opportunities where possible. The impacted employees will receive local severance in accordance with Company policy, as well as works council and labor union agreements.
"While closing facilities is never an easy decision, it is based on a realistic expectation of current and future capacity needs, operating costs and an unrelenting focus on improving our business," said Tony Smurfit, President &amp; Group Chief Executive Officer, Smurfit Westrock. "We are very grateful for the significant contributions made by the teams at these locations over the years and we will do all we can to support them throughout this process."

Smurfit Westrock Announces It Will Permanently Close Its Coated Recycled Board Mill in St. Paul, Minnesota Will Discontinue Production at Its Containerboard Mill in Forney, Texas

Columbia Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBK#NASDAQ">CLBK</a>) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is a 2150 percent increase over earnings of $0.00 per share from the same period last year. The company reported quarterly sales of $58.80 million which beat the analyst consensus estimate of $49.95 million by 17.71 percent. This is a 18.40 percent increase over sales of $49.66 million the same period last year.

CLBK

Columbia Financial Q1 Adj. EPS $0.09, Inline, Sales $58.80M Beat $49.95M Estimate

Barrington Research analyst Gary Prestopino maintains Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) with a Outperform and lowers the price target from $410 to $380.

Price Target

Analyst Ratings

Barrington Research Maintains Outperform on Kadant, Lowers Price Target to $380

Jacobs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) announced today that its Board of Directors approved a special dividend of 7,299,065 shares of common stock of Amentum Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTM#NYSE">AMTM</a>) ("Amentum") distributable to Jacobs' shareholders of record as of the close of business on May 16, 2025 (the "Amentum Share Dividend"). Jacobs expects the Amentum Share Dividend to be made on May 30, 2025. No shareholder action is necessary to receive the Amentum Share Dividend.&nbsp;

Dividends

AMTM

Jacobs Solutions Announces Special Dividend Of 7,299,065 Shares Of Amentum Common Stock

Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) lowers FY2025 sales outlook from $1.90 billion-$2.05 billion to $1.82 billion-$1.90 billion vs $1.93 billion estimate.

Guidance

Ashland Lowers FY2025 Sales Guidance from $1.90B-$2.05B to $1.82B-$1.90B vs $1.93B Est

Tiptree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIPT#NASDAQ">TIPT</a>) reported quarterly earnings of $0.13 per share. This is a 40.91 percent decrease over earnings of $0.22 per share from the same period last year. The company reported $497.43 million in sales this quarter. This is a 0.16 percent decrease over sales of $498.22 million the same period last year.

TIPT

Tiptree Q1 EPS $0.13 Down From $0.22 YoY, Sales $497.43M Down From $498.22M YoY

Exco Technologies (TSX:<a class="ticker" href="https://www.benzinga.com/stock/XTC#TSX">XTC</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.10 by 70 percent. This is a 19.05 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $166.12 million which beat the analyst consensus estimate of $152.90 million by 8.64 percent. This is a 1.40 percent increase over sales of $163.82 million the same period last year.

TSX:XTC

Exco Technologies Q2 EPS $0.17 Beats $0.10 Estimate, Sales $166.12M Beat $152.90M Estimate

X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement.
Analysts estimate that X4 Pharmaceuticals will report an earnings per share (EPS) of $-0.15. 
X4 Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.04, leading to a 3.86% increase in the share price on the subsequent day.
Here's a look at X4 Pharmaceuticals's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.16</td>
<td>-0.17</td>
<td>0.01</td>
<td>-0.16</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.20</td>
<td>-0.18</td>
<td>-0.07</td>
<td>-0.26</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>48.0%</td>
<td>-3.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746046971_0.png" alt="eps graph" />
<h3>Performance of X4 Pharmaceuticals Shares</h3>
Shares of X4 Pharmaceuticals were trading at $4.35 as of April 29. Over the last 52-week period, shares are down 86.7%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/XFOR/earnings">To track all earnings releases for X4 Pharmaceuticals visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

XFOR

Earnings Preview For X4 Pharmaceuticals

FTC Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCI#NASDAQ">FTCI</a>) is preparing to release its quarterly earnings on Thursday, 2025-05-01. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect FTC Solar to report an earnings per share (EPS) of $-0.58.
The announcement from FTC Solar is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Overview of Past Earnings</h3>
Last quarter the company beat EPS by $0.04, which was followed by a 4.18% drop in the share price the next day.
Here's a look at FTC Solar's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.84</td>
<td>-0.8</td>
<td>-0.9</td>
<td>-0.9</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.80</td>
<td>-1</td>
<td>-0.9</td>
<td>-0.9</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-3.0%</td>
<td>-3.0%</td>
<td>-15.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746046963_0.png" alt="eps graph" />
<h3>FTC Solar Share Price Analysis</h3>
Shares of FTC Solar were trading at $3.42 as of April 28. Over the last 52-week period, shares are down 31.59%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/FTCI/earnings">To track all earnings releases for FTC Solar visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FTCI

Earnings Outlook For FTC Solar

Kirkland's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIRK#NASDAQ">KIRK</a>) will release its quarterly earnings report on Thursday, 2025-05-01. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Kirkland's to report an earnings per share (EPS) of $0.59.
The announcement from Kirkland's is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS missed by $0.02, leading to a 0.0% drop in the share price on the subsequent day.
Here's a look at Kirkland's's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.27</td>
<td>-1.31</td>
<td>-0.92</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.29</td>
<td>-1.11</td>
<td>-0.68</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746046956_0.png" alt="eps graph" />
<h3>Kirkland's Share Price Analysis</h3>
Shares of Kirkland's were trading at $1.37 as of April 29. Over the last 52-week period, shares are down 29.08%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/KIRK/earnings">To track all earnings releases for Kirkland's visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KIRK

Earnings Preview For Kirkland's

Press Releases

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement

Elanco Reinforces Commitment to Veterinary and Pet Owner Education

Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-Formulated Supplements for Complete Pet Wellness

Elanco to Participate in Upcoming Investor Conferences

Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle

Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results

Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets

Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement

Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day

Legal

ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Elanco Animal Health Incorporated on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

ELAN

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Elanco Animal Health

空売り

Elanco Animal Health (NYSE:ELAN) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル